304 related articles for article (PubMed ID: 26980944)
41. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.
Iruretagoyena MI; Sepúlveda SE; Lezana JP; Hermoso M; Bronfman M; Gutiérrez MA; Jacobelli SH; Kalergis AM
J Pharmacol Exp Ther; 2006 Jul; 318(1):59-67. PubMed ID: 16597709
[TBL] [Abstract][Full Text] [Related]
42. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance.
Diehl L; Schurich A; Grochtmann R; Hegenbarth S; Chen L; Knolle PA
Hepatology; 2008 Jan; 47(1):296-305. PubMed ID: 17975811
[TBL] [Abstract][Full Text] [Related]
43. Dendritic cells and the immunity/tolerance decision.
Usharauli D
Med Hypotheses; 2005; 64(1):112-3. PubMed ID: 15533624
[TBL] [Abstract][Full Text] [Related]
44. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
45. Protein kinase C inhibitor generates stable human tolerogenic dendritic cells.
Matsumoto T; Hasegawa H; Onishi S; Ishizaki J; Suemori K; Yasukawa M
J Immunol; 2013 Sep; 191(5):2247-57. PubMed ID: 23878315
[TBL] [Abstract][Full Text] [Related]
46. Role of dendritic cells in Sjögren's syndrome.
Vogelsang P; Jonsson MV; Dalvin ST; Appel S
Scand J Immunol; 2006 Sep; 64(3):219-26. PubMed ID: 16918690
[TBL] [Abstract][Full Text] [Related]
47. Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation.
Svajger U; Rozman P
J Leukoc Biol; 2014 Jan; 95(1):53-69. PubMed ID: 24108704
[TBL] [Abstract][Full Text] [Related]
48. Leishmaniasis, contact hypersensitivity and graft-versus-host disease: understanding the role of dendritic cell subsets in balancing skin immunity and tolerance.
Kautz-Neu K; Meyer RG; Clausen BE; von Stebut E
Exp Dermatol; 2010 Aug; 19(8):760-71. PubMed ID: 20590820
[TBL] [Abstract][Full Text] [Related]
49. Tolerogenic dendritic cells: the ins and outs of outcome.
Xiao BG; Huang YM; Link H
J Immunother; 2006; 29(5):465-71. PubMed ID: 16971802
[TBL] [Abstract][Full Text] [Related]
50. Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage.
Silva Pde M; Bier J; Paiatto LN; Galdino Albuquerque C; Lopes Souza C; Fernandes LG; Tamashiro WM; Simioni PU
J Immunol Res; 2015; 2015():856707. PubMed ID: 26543876
[TBL] [Abstract][Full Text] [Related]
51. Characterization of Dendritic Cell Metabolism by Flow Cytometry.
Brombacher EC; Patente TA; Quik M; Everts B
Methods Mol Biol; 2023; 2618():219-237. PubMed ID: 36905520
[TBL] [Abstract][Full Text] [Related]
52. Tumor-host immune interactions and dendritic cell dysfunction.
Yang L; Carbone DP
Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
[TBL] [Abstract][Full Text] [Related]
53. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype.
Gleisner MA; Rosemblatt M; Fierro JA; Bono MR
Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264
[TBL] [Abstract][Full Text] [Related]
54. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
Boks MA; Zwaginga JJ; van Ham SM; ten Brinke A
Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
[TBL] [Abstract][Full Text] [Related]
55. Potential of tolerogenic dendritic cells for transplantation.
Morelli AE; Hackstein H; Thomson AW
Semin Immunol; 2001 Oct; 13(5):323-35. PubMed ID: 11502167
[TBL] [Abstract][Full Text] [Related]
56. Tolerogenic dendritic cells as a therapy for treating lupus.
Llanos C; Mackern-Oberti JP; Vega F; Jacobelli SH; Kalergis AM
Clin Immunol; 2013 Aug; 148(2):237-45. PubMed ID: 23773922
[TBL] [Abstract][Full Text] [Related]
57. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells.
Volchenkov R; Karlsen M; Jonsson R; Appel S
Scand J Immunol; 2013 Apr; 77(4):246-54. PubMed ID: 23442246
[TBL] [Abstract][Full Text] [Related]
58. In vitro-generated DC with tolerogenic functions: perspectives for in vivo cellular therapy.
van Kooten C; Gelderman KA
Methods Mol Biol; 2011; 677():149-59. PubMed ID: 20941608
[TBL] [Abstract][Full Text] [Related]
59. Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells.
Ferreira GB; Kleijwegt FS; Waelkens E; Lage K; Nikolic T; Hansen DA; Workman CT; Roep BO; Overbergh L; Mathieu C
J Proteome Res; 2012 Feb; 11(2):941-71. PubMed ID: 22103328
[TBL] [Abstract][Full Text] [Related]
60. Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.
Turnquist HR; Thomson AW
Curr Opin Organ Transplant; 2008 Aug; 13(4):350-7. PubMed ID: 18685329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
